9 Reasons to Buy Pfizer in 2018 and 1 Big One Not To Post author:Sam Post published:December 21, 2017 Post category:BioPharma Pfizer may be the surprise strong-growth stock for next year. Source: BioSpace You Might Also Like Why You Want to Keep This Small $2 Biotech Stock On Your Radar August 1, 2017 Glytec Nabs Fourth FDA 510(k) Clearance for Its Market-Leading Diabetes Therapy Management Software August 15, 2017 EnteroMedics Announces Proposed Underwritten Public Offering August 10, 2017
Glytec Nabs Fourth FDA 510(k) Clearance for Its Market-Leading Diabetes Therapy Management Software August 15, 2017
